Antidepressant pharmacotherapy failure and response to subsequent electroconvulsive therapy: A meta-analysis

Journal of Clinical Psychopharmacology

Volumn 30, Issue 5, 2010, Pages 616-619

  Heijnen, Willemijn T ^a   Birkenhäger, Tom K ^a   Wierdsma, André I ^a   Van Den Broek, Walter W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

electroconvulsive therapy; major depression; medication resistance; meta analysis

Indexed keywords

ANTIDEPRESSANT AGENT;

ARTICLE; CLINICAL TRIAL; DEPRESSION; ELECTROCONVULSIVE THERAPY; HUMAN; MAJOR DEPRESSION; MANTEL HAENSZEL TEST; META ANALYSIS; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; REMISSION; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW; TREATMENT FAILURE; TREATMENT RESPONSE;

ANTIDEPRESSIVE AGENTS; COHORT STUDIES; DEPRESSIVE DISORDER, MAJOR; ELECTROCONVULSIVE THERAPY; HUMANS; PROSPECTIVE STUDIES; TREATMENT FAILURE;

EID: 77957271805     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/JCP.0b013e3181ee0f5f     Document Type: Article

References (25)

1. Fink M. History of convulsive therapies. In: Fink M, ed. Convulsive Therapy: Theory and Practice. New York, NY: Raven Press; 1979: 5-17.
2. Prudic J, Sackeim HA, Devanand DP. Medication resistance and clinical response to electroconvulsive therapy. Psychiatry Res. 1990;31: 287-296. (Pubitemid 20102377)
3. Prudic J, Haskett RF, Mulsant B, et al. Resistance to antidepressant medications and short-term clinical response to ECT. Am J Psychiatry. 1996;153: 985-992. (Pubitemid 26264697)
4. Dombrovski AY, Mulsant BH, Haskett RF, et al. Predictors of remission after electroconvulsive therapy in unipolar major depression. J Clin Psychiatry. 2005;66: 1043-1049. (Pubitemid 41191798)
5. Pluijms EM, Birkenhäger TK, Huijbrechts IP, et al. Influence of resistance to antidepressant pharmacotherapy on short-term response to electroconvulsive therapy. J Affect Disord. 2002;69: 93-99.
6. van den Broek WW, de Lely A, Mulder PG, et al. Effect of antidepressant medication resistance on short-term response to electroconvulsive therapy. J Clin Psychopharmacol. 2004;24: 400-403. (Pubitemid 38944138)
7. Husain SS, Kevan IM, Linnell R, et al. Electroconvulsive therapy in depressive illness that has not responded to drug treatment. J Affect Disord. 2004;83: 121-126. (Pubitemid 39536185)
8. Rasmussen KG, Mueller M, Knapp RG, et al. Antidepressant medication treatment failure does not predict lower remission with ECT for major depressive disorder: a report from the consortium for research in electroconvulsive therapy. J Clin Psychiatry. 2007;68: 1701-1706. (Pubitemid 350247499)
9. Heijnen WT, van den Broek WW, Birkenhäger TK. Treatment failure with a tricyclic antidepressant followed by lithium addition and response to subsequent electroconvulsive therapy. J Clin Psychiatry. 2008;69: 1887-1891.
10. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23: 56-62.
11. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134: 382-389. (Pubitemid 9136500)
12. Rasmussen KG, Mueller M, Rummans TA, et al. Is baseline medication resistance associated with potential for relapse after successful remission of a depressive episode with ECT? Data from the consortium for research in electroconvulsive therapy (CORE). J Clin Psychiatry. 2009;71: 232-237.
13. van den Broek WW, Birkenhäger TK, Mulder PG, et al. Imipramine is effective in preventing relapse in electroconvulsive therapyYresponsive depressed inpatients with prior pharmacotherapy treatment failure: a randomized, placebo-controlled trial. J Clin Psychiatry. 2006;67: 263-268.
14. Devanand DP, Sackeim HA, Prudic J. Electroconvulsive therapy in the treatment-resistant patient. Psychiatr Clin North Am. 1991;14: 905-923.
15. Sackeim HA, Prudic J, Devanand DP, et al. The impact of medication resistance and continuation pharmacotherapy on relapse following response to electroconvulsive therapy in major depression. J Clin Psychopharmacol. 1990;10: 96-104. (Pubitemid 20137605)
16. Shapira B, Gorfine M, Lerer B. A prospective study of lithium continuation therapy in depressed patients who have responded to electroconvulsive therapy. Convuls Ther. 1995;11: 80-85.
17. Sackeim HA. Continuation therapy following ECT: directions for future research. Psychopharmacol Bull. 1994;30: 501-521.
18. Sackeim HA, Prudic J, Devanand DP, et al. A prospective, randomized double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities. Arch Gen Psychiatry. 2000;57: 425-434. (Pubitemid 30257256)
19. Sackeim HA, Haskett RF, Mulsant BH, et al. Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial. JAMA. 2001;285: 1299-1307.
20. Prudic J, Olfson M, Marcus SC, et al. Effectiveness of electroconvulsive therapy in community Settings. Biol psychiatry. 2004;55: 301-312. (Pubitemid 38117168)
21. Sackeim HA, Prudic J, Nobler MS, et al. Effects of pulse width and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. Brain Stimulation. 2008;1: 71-83. (Pubitemid 351698629)
22. Sackeim HA, Dillingham EM, Prudic J, et al. Effect of concomitant pharmacotherapy on electroconvulsive therapy outcomes: short-term efficacy and adverse effects. Arch Gen Psychiatry. 2009;66: 729-737.
23. Petrides G, Fink M, Husain MM, et al. ECT remission rates in psychotic versus nonpsychotic depressed patients: a report from CORE. J ECT. 2001;17: 244-253. (Pubitemid 33131305)
24. Birkenhäger TK, Pluijms EM, Lucius SA. ECT response in delusional versus nondelusional depressed inpatients. J Affect Disord. 2003;74: 191-195.
25. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology. JAMA. 2000;283: 2008-2012.